Lifecore Biomedical, Inc.
LFCR
$6.38
$0.213.40%
NASDAQ
| 02/23/2025 | 11/24/2024 | 08/25/2024 | 05/26/2024 | 02/25/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.77M | -6.57M | -16.23M | -7.08M | 15.63M |
| Total Depreciation and Amortization | 2.08M | 2.04M | 1.99M | 1.75M | 2.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | 500.00K | -- |
| Total Other Non-Cash Items | 16.33M | 7.11M | 6.13M | 8.92M | -14.32M |
| Change in Net Operating Assets | -2.44M | -8.70M | 7.47M | 4.55M | -4.73M |
| Cash from Operations | 1.20M | -6.11M | -643.00K | 8.64M | -1.42M |
| Capital Expenditure | -5.46M | -2.47M | -3.39M | -2.64M | -6.37M |
| Sale of Property, Plant, and Equipment | 7.00M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.54M | -2.47M | -3.39M | -2.64M | -6.37M |
| Total Debt Issued | -- | -1.91M | 1.91M | 146.48M | 3.04M |
| Total Debt Repaid | -6.23M | -11.43M | -233.00K | -146.94M | -232.00K |
| Issuance of Common Stock | 17.00K | 23.84M | 1.00K | 0.00 | 0.00 |
| Repurchase of Common Stock | -133.00K | -385.00K | -589.00K | -53.00K | -42.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -435.00K | 2.40M | -- | -107.00K | 4.88M |
| Cash from Financing | -6.78M | 12.52M | 1.09M | -614.00K | 7.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.04M | 3.94M | -2.94M | 5.39M | -148.00K |